Jaguar Health Inc expected to post a loss of $7.13 a share - Earnings Preview

Jaguar Health

08/08/2025 18:50

Jaguar Health Inc JAGX.OQ JAGX.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 (estimated) for the period ending June 30 2025

The San Francisco California-based  company is expected to report a 20.0% increase in revenue to $3.265 million from $2.72 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Jaguar Health Inc is for a loss of $7.13 per share.

The one available analyst rating on the shares is "strong buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Jaguar Health Inc is $16.00, about 86.9% above its last closing price of $2.10

This summary was machine generated August 8 at 17:50 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)